Please assess the completion status of the following clinical trial:

Trial Title: Lactated Ringers With or Without Rectal Indomethacin to Prevent Post-ERCP Pancreatitis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~1 Subjects who are undergoing endoscopic retrograde cholangiopancreatography (ERCP)~* Age \> 18 years~* Non-pregnant~* Non-prisoners~* Subjects who can sign informed consent~* Serum Creatinine \< 1.2 milligrams/deciliter (mg/dL)~* Subjects without renal failure (acute or chronic)~* Subjects without congestive heart failure (ejection fraction \< 40%)~* Subjects without cirrhosis of the liver~* Subjects without allergy to aspirin or non-steroidal anti-inflammatory drugs (NSAIDS)~* Subjects not on non-steroidal anti-inflammatory drugs NSAIDS prior to enrollment~Exclusion Criteria:~* Subjects who are not undergoing ERCP~* Age \< 18 years~* Pregnancy~* Prisoners~* Subjects lacking the capacity to consent for themselves~* Serum Creatinine \> 1.2 milligrams/deciliter (mg/dL)~* Subjects with renal failure (acute and chronic)~* Subjects with congestive heart failure (ejection fraction \< 40%)~* Subjects with cirrhosis of the liver~* Subjects with allergy to aspirin or non-steroidal anti-inflammatory drugs (NSAIDS)~* Subjects with gastrointestinal hemorrhage~* Subjects on chronic non-steroidal anti-inflammatory drugs NSAIDS~* Subjects with acute pancreatitis the day of their procedure (CITE 1-3)(APPENDIX 1)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- A (NS+Placebo) (Type: PLACEBO_COMPARATOR): Normal Saline (intravenous during procedure) + Placebo (100mg suppository per rectum prior to procedure )
- B (NS+IND) (Type: ACTIVE_COMPARATOR): Normal Saline (intravenous during procedure) + Indomethacin (100mg suppository per rectum prior to procedure )
- C (LR+Placebo) (Type: ACTIVE_COMPARATOR): Lactated ringer's solution (1 Liter, intravenous prior to procedure) + Placebo (100mg suppository per rectum prior to procedure)
- D (LR+IND) (Type: EXPERIMENTAL): Lactated ringer's solution (1 Liter, intravenous prior to procedure) + Indomethacin (100mg suppository per rectum prior to procedure)

Based on this trial design, predict the completion outcome and termination type (if applicable).